A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, opening new possibilities for cancer therapy.



Summary

Researchers have created a targeted lung cancer therapy using nanobodies. These tiny antibodies are engineered to specifically recognize and bind to lung cancer cells, leaving healthy cells unharmed. This precise targeting mechanism offers a significant advantage over traditional chemotherapy, which often damages healthy tissues alongside cancerous ones. By selectively attacking lung cancer cells, this nanobody-based technology holds promise for more effective and less toxic cancer treatments, potentially improving patient outcomes and reducing debilitating side effects. This innovative approach represents a significant advancement in precision medicine for lung cancer.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer